Lycopodium Ltd (LYL) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Lycopodium Ltd stock A$21.56, price A$19.75, upside +9.2%, quality 70 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.
How to read this chart
60‑month range A$3.21 – A$24.45 · fair‑value band A$16.80 – A$26.31 · the A$19.75 price screens below the A$21.56 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.
Follow Lycopodium in your weekly email
Every Wednesday you see whether Lycopodium is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Lycopodium Limited provides engineering and project delivery services in the resources, rail infrastructure, and industrial processes sectors in Australia. It operates through four segments: Resources, Industrial Process, Rail Infrastructure, and Others.
Show moreShow less
The company offers engineering and related services, including process plant and equipment, civil building works, control systems, services, and infrastructure to the mining industry; and engineering and related services to manufacturing and renewable energy facilities.
It also provides asset management, engineering, architectural and project delivery services to private and public clients; and metallurgical consulting services to mineral processing community in the field of comminution, hydrometallurgy, and mineral processing design.
In addition, the company offers feasibility studies and advisory; process development and optimization; process control and optimization; project management and control; construction management; commissioning and operation support; and performance assessment and improvement.
The company was founded in 1992 and is headquartered in East Perth, Australia.
Stock analysis
Lycopodium Ltd (LYL) currently trades at A$19.75, while our model-based Fair Value estimate is A$21.56, so the stock looks roughly fairly valued today (gap 8.4%).
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of A$26.20 per share, and 14 of the 26 models we run sit above the A$19.75 price.
Bear case: the Asset-Based group reads lowest at A$3.05, and 12 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: A$16.80 (bear) to A$26.31 (bull), the price of A$19.75 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Industrials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Lycopodium Ltd reported revenue of A$374M in FY2026 versus A$229M in FY2022, a compound +13.1%/yr. Reported net income was A$40.2M in FY2026, compounding +10.3%/yr from FY2022.
Key figures
Market cap A$773M (≈ $533M) Small · P/E ratio 19.2 · P/S ratio 2.07 · EPS (TTM) A$1.03 · Dividend yield 2.4% · Net margin 10.7% · Return on equity 25.3% · Return on assets (EBIT) 21.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 64 out of 100 (low confidence).
What moves the price
The share trades about 19% below its 52-week high and 61% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −42% fair-value upside, at 9%, LYL screens cheaper than that median.
Fair Value models
BearA$16.80Fair Value A$21.56BullA$26.31
Price A$19.75 · Upside +9.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 4 months old). Earnings retained since then (A$0.1953 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+12.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.8%
Start year 2021 (pandemic). Over 10 years: +11.6% a year
Revenue growth 24 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.7%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+26.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+23.7%
Dividend (yield on the price)2.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.base effect: 23.7% / 19.8%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 12%
Pace: the 5-year rate starts in 2021 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−1.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Australia: IMF forecast 3.0% a year to 2030, 2.9% from 2016 to 2025) that is about −3.9% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Engineering & Construction · 791 stocks
Beats the industry median on 8/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside+9.2% · Above median
Profitability
Return on equity (12 months)25.3% · Top 25%
Return on assets13.5% · Top 25%
Net margin (12 months)10.7% · Top 25%
Operating margin (12 months)10.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)19.3% · Above median
Dividend yield (12 months)2.4% · Above median
Valuation Multiplesvs Engineering & Construction median · lower = cheaper
P/E (12 months)19.2× · Pricier than median
P/B4.55× · Priciest 25%
P/S (12 months)2.07× · Priciest 25%
Price / free cash flow (fiscal year)13.0× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Lycopodium Ltd Fair Value". https://www.fairvalue-calculator.com/stock/LYL
Frequently asked questions
Is Lycopodium Ltd (LYL) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of A$21.56 versus a price of A$19.75, about +9% upside (fairly valued).
What is the fair value of LYL?
Our model-based fair value for Lycopodium Ltd is A$21.56 (as of Nov 7, 2026), built from audited fundamentals. The current price: A$19.75.
What is the quality score of LYL?
Lycopodium Ltd has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Lycopodium Ltd (LYL)?
Our model-based price target is the fair value of A$21.56 (as of Nov 7, 2026) from 26 valuation models. Cautious scenario A$16.80, optimistic scenario A$26.31. It is a calculation from audited fundamentals, not an analyst target.
What is the Lycopodium Ltd stock forecast for 2026?
Our models put fair value at A$21.56, about +9% upside versus a price of A$19.75 (fairly valued). Cautious scenario A$16.80, optimistic scenario A$26.31. The calculation is refreshed regularly with new filings.
What is the revenue of Lycopodium Ltd (LYL)?
Lycopodium Ltd reported trailing-twelve-month revenue of about A$374M (latest available figure, as of Nov 7, 2026).
Does Lycopodium Ltd pay a dividend?
Lycopodium Ltd currently shows a dividend yield of 2.38% relative to its recent price (as of Nov 7, 2026).
How much is the dividend of Lycopodium Ltd (LYL) and when is the ex-dividend date?
Lycopodium Ltd pays a dividend of A$0.47 per share a year, a dividend yield of 2.4%. The last ex-dividend date was Sep 17, 2026. A dividend has been paid every year since at least 2005. The payout ratio is 46.5% of earnings. Free cash flow covers the dividend 3.17 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Lycopodium Ltd (LYL)?
For today's price to be fair in a discounted-cash-flow model, Lycopodium Ltd would have to grow free cash flow by -1.1 % per year for five years (discount rate 9.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +18.8 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of LYL use?
Our models discount Lycopodium Ltd at 9.6 %: a base by market capitalisation (small), damped by beta 0.15, country premium for Australia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Lycopodium Ltd that is -1.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.6 %) and the same formula as our fair value.
How much growth has Lycopodium Ltd (LYL) delivered so far?
Over the past 5 years revenue at Lycopodium Ltd grew +18.8 % a year. The price currently implies free-cash-flow growth of -1.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Lycopodium Ltd (LYL) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Lycopodium Ltd (-1.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Lycopodium Ltd (LYL)?
The free-cash-flow yield on the price is 7.67 %: that much free cash flow Lycopodium Ltd produces per unit of market value. When it exceeds the discount rate of our models (9.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Lycopodium Ltd (LYL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Lycopodium Ltd it is A$21.56 per share (as of Nov 7, 2026), against a price of A$19.75. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Lycopodium Ltd stock overvalued or undervalued in 2026?
As of Nov 7, 2026, LYL trades below its calculated fair value: price A$19.75, fair value A$21.56, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LYL?
No. The price is what the market pays today (A$19.75); the fair value is what the company's own numbers justify (A$21.56). For Lycopodium Ltd the two are A$1.81 per share apart. That gap is exactly why we show both numbers side by side.
How much is Lycopodium Ltd worth?
The market values Lycopodium Ltd at about A$773M (market capitalisation, as of Nov 7, 2026). Per share that is A$19.75; our models calculate a fair value of A$21.56 per share.
What do the bullish and bearish scenarios say about LYL?
Our models span a range for Lycopodium Ltd: cautious scenario A$16.80, base A$21.56, optimistic A$26.31 per share (as of Nov 7, 2026, price A$19.75). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of LYL?
Lycopodium Ltd trades at a price-to-earnings ratio of 19.2 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of A$21.56 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2017 to 2026), reported earnings, FY2026 ex one-offs: 10.9. Other multiples: PEG 2.4, P/B 4.6, P/S 2.1, EV/EBITDA 14.1.
What is the PEG ratio of LYL?
The PEG ratio of Lycopodium Ltd is 2.44 (P/E divided by earnings growth, as of Nov 7, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Lycopodium Ltd (LYL)?
Balance-sheet figures for Lycopodium Ltd (as of Nov 7, 2026): return on equity 25.3%. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is LYL from its 52-week high?
Lycopodium Ltd trades at A$19.75, about 19% below its 52-week high of A$24.45 and 61% above the low of A$12.25 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of A$21.56 is for.
Which stocks are comparable to Lycopodium Ltd?
From the same area (Industrials) we also value Quanta Services, Inc, Vinci SA, Larsen & Toubro Limited, Comfort Systems USA, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Lycopodium Ltd stock attractive at the current price?
The data as of Nov 7, 2026: price A$19.75, calculated fair value A$21.56 (+9%), Quality Score 70/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LYL calculated?
We run Lycopodium Ltd through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of A$21.56 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Lycopodium Ltd currently trades 8% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Lycopodium Ltd (LYL)?
The closing price on Nov 9, 2026 was A$19.75. Our model-based fair value is A$21.56, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Lycopodium Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Lycopodium Ltd (LYL) come from?
Earnings per share at Lycopodium Ltd grew +24.9 % a year from 2016 to 2026. Broken into its drivers: revenue per share +8.9 %, EBIT margin +13.3 %, tax rate +0.6 %, residual (interest, one-offs) +0.6 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Lycopodium Ltd
How large is the market capitalisation of Lycopodium Ltd (LYL)?
The market capitalisation of Lycopodium Ltd is A$773M (≈ $533M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Lycopodium Ltd (LYL)?
The price-to-sales ratio of Lycopodium Ltd is 2.07 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Lycopodium Ltd (LYL)?
Earnings per share at Lycopodium Ltd are A$1.03 (price ÷ EPS = P/E 19.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Lycopodium Ltd (LYL)?
The dividend yield of Lycopodium Ltd is 2.4% (payout 45.8%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Lycopodium Ltd (LYL)?
The net margin of Lycopodium Ltd is 10.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Lycopodium Ltd (LYL)?
The return on equity (ROE) of Lycopodium Ltd is 25.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Lycopodium Ltd (LYL)?
On an EBIT basis the return on assets of Lycopodium Ltd is 21.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Lycopodium Ltd (LYL)?
The operating margin of Lycopodium Ltd is 10.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Lycopodium Ltd (LYL)?
Revenue at Lycopodium Ltd is growing +19.3% versus a year earlier (3y avg +4.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Lycopodium Ltd (LYL)?
Earnings per share at Lycopodium Ltd are growing +29.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Lycopodium Ltd (LYL) hold?
Lycopodium Ltd holds more cash than debt, A$93.7M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Lycopodium Ltd in the live analysis
One click puts Lycopodium Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 7, 2026